No Data
Dow's 175-Point Drop Led By Losses For Shares Of Chevron, Apple
Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show
Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why.
Express News | UBS Maintains Neutral on Amgen, Lowers Price Target to $315
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data
Express News | RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $320